by Elena Iemma | Oct 29, 2024 | Uncategorized
October is Rocking! Off to Amsterdam and Stockholm EpiVax Sets the Standards for the Generic Drug Industry Ok . . . that’s an over-the-top headline! But read the press release! It reflects our excitement about our new contract with...
by Elena Iemma | Oct 24, 2024 | News
PROVIDENCE, R.I., Oct. 24, 2024 /PRNewswire/ — EpiVax, Inc. and CUBRC, Inc. announce today that they have been awarded a two-year, $2 million contract (#75F40124C00094) from the Office of Generic Drugs (OGD) of the Food and Drug...
by Elena Iemma | Oct 18, 2024 | Events, News
The 10th annual Amsterdam Immunogenicity and Tolerance Seminar was a fantastic success, bringing together a passionate group of immunology and vaccinology experts to explore new frontiers in the field. The morning sessions focused on protein therapeutics, with...
by Elena Iemma | Sep 16, 2024 | Uncategorized
September Falling Forward The Transition Suddenly, summer is over! No more long bike rides, afternoon sailing sessions, or dinners in the back yard. We have fall to look forward to and in New England, that means crisp days and colorful foliage. Fall also brings...
by Elena Iemma | Apr 11, 2024 | Events
Thank you for participating in the first ever AI / Computational Vaccinology Symposium! Check out these photos from the event. A special thank you to the event organizing committee: Yoshimasa Takahashi, Ph.D. National Institute of Infectious Diseases, Japan;...
